Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities
- PMID: 17001464
- DOI: 10.1007/s11102-006-0265-2
Pituitary pathology in patients with Carney Complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities
Abstract
First described in the mid 80's, Carney Complex (CNC) is a rare, dominantly heritable disorder with features overlapping those of McCune-Albright syndrome (MAS) and other multiple endocrine neoplasia (MEN) syndromes like MEN type 1 (MEN 1). Pituitary tumors have been described in a number of patients with CNC; they present with elevated growth hormone (GH) levels and mild hyperprolactinemia. However, most patients with CNC have mild hypersomatomammotropinemia starting in adolescence; this is similar to the situation in MAS patients: in both disorders, pituitary hyperplasia appears to precede tumor development. Familial pituitary tumor syndromes such as CNC provide an important insight into the genetics and molecular pathology of pituitary and other endocrine tumors. Our understanding of these conditions is expanding rapidly due to the identification of the causative genes and the availability of murine disease models. The present report reviews the clinical findings related to pituitary tumor development among patients with CNC and provides an update on murine models of the complex.
Similar articles
-
Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex).Front Horm Res. 2004;32:253-64. doi: 10.1159/000079049. Front Horm Res. 2004. PMID: 15281351 Review.
-
Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).J Clin Endocrinol Metab. 2000 Oct;85(10):3860-5. doi: 10.1210/jcem.85.10.6875. J Clin Endocrinol Metab. 2000. PMID: 11061550 Clinical Trial.
-
Pituitary pathology in Carney complex patients.Pituitary. 2004;7(2):73-82. doi: 10.1007/s11102-005-5348-y. Pituitary. 2004. PMID: 15761655 Free PMC article.
-
Carney complex: pathology and molecular genetics.Neuroendocrinology. 2006;83(3-4):189-99. doi: 10.1159/000095527. Neuroendocrinology. 2006. PMID: 17047382 Review.
-
Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.Clin Endocrinol (Oxf). 2002 Oct;57(4):443-8. doi: 10.1046/j.1365-2265.2002.01643.x. Clin Endocrinol (Oxf). 2002. PMID: 12354125
Cited by
-
Corticotropinoma as a Component of Carney Complex.J Endocr Soc. 2017 May 30;1(7):918-925. doi: 10.1210/js.2017-00231. eCollection 2017 Jul 1. J Endocr Soc. 2017. PMID: 29264542 Free PMC article.
-
Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.Endocrinology. 2008 Aug;149(8):4158-67. doi: 10.1210/en.2007-1760. Epub 2008 May 1. Endocrinology. 2008. PMID: 18450960 Free PMC article.
-
Familial pituitary tumor syndromes.Nat Rev Endocrinol. 2009 Aug;5(8):453-61. doi: 10.1038/nrendo.2009.126. Epub 2009 Jun 30. Nat Rev Endocrinol. 2009. PMID: 19564887 Review.
-
Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family.Int J Endocrinol. 2018 Apr 4;2018:8581626. doi: 10.1155/2018/8581626. eCollection 2018. Int J Endocrinol. 2018. PMID: 29849625 Free PMC article.
-
The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation.Insights Imaging. 2013 Feb;4(1):119-33. doi: 10.1007/s13244-012-0208-6. Epub 2013 Jan 12. Insights Imaging. 2013. PMID: 23315333 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical